Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ulrik Mouritzen"'
Autor:
Chelsy L. Cliff, Bethany M. Williams, Christos E. Chadjichristos, Ulrik Mouritzen, Paul E. Squires, Claire E. Hills
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 2, p 600 (2022)
Of increasing prevalence, diabetes is characterised by elevated blood glucose and chronic inflammation that precedes the onset of multiple secondary complications, including those of the kidney and the eye. As the leading cause of end stage renal dis
Externí odkaz:
https://doaj.org/article/5488b82fc47c4609b76a49db29ce70cb
Autor:
Paul E. Squires, Gareth W. Price, Ulrik Mouritzen, Joe A. Potter, Bethany M. Williams, Claire E. Hills
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 6, p 2809 (2021)
Chronic kidney disease (CKD) is a global health problem associated with a number of comorbidities. Recent evidence implicates increased hemichannel-mediated release of adenosine triphosphate (ATP) in the progression of tubulointerstitial fibrosis, th
Externí odkaz:
https://doaj.org/article/8e95d8a526234043bb974ca2ff600f5f
Autor:
Grant McArthur, Paul E.G. Kristjansen, Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Kresten Skak, Lasse Tengbjerg Hansen, Ulrik Mouritzen, Birte K. Skrumsager, Jonathan Cebon, Michael Millward, Richard F. Kefford, Ben Brady, Ian D. Davis
Purpose: Human interleukin-21 (IL-21) is a class I cytokine that mediates activation of CD8+ T cells, natural killer (NK) cells, and other cell types. We report final clinical and biological results of a phase II study of recombinant human IL-21 (rIL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d697d62b9970cc19d254b96f83eeba4
https://doi.org/10.1158/1078-0432.c.6517471
https://doi.org/10.1158/1078-0432.c.6517471
Autor:
Grant McArthur, Paul E.G. Kristjansen, Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Kresten Skak, Lasse Tengbjerg Hansen, Ulrik Mouritzen, Birte K. Skrumsager, Jonathan Cebon, Michael Millward, Richard F. Kefford, Ben Brady, Ian D. Davis
Supplementary Figures S1-S3 from Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cebdd282d68de54e04690086196625c
https://doi.org/10.1158/1078-0432.22440097.v1
https://doi.org/10.1158/1078-0432.22440097.v1
Autor:
Daniela Lamers, Ulrik Mouritzen, Ulrike Hövelmann, Tim Heise, Minna Braendholt Olsen, Birgit Kronshage
Publikováno v:
Diabetes, Obesity & Metabolism
AIM To characterize the pharmacokinetic and pharmacodynamic properties of dasiglucagon, a novel, stable and liquid formulated glucagon analogue, during hypoglycaemic and euglycaemic conditions in adult patients with type 1 diabetes mellitus. RESEARCH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f21c5aeb2d9443e70883f8020af9b91
http://europepmc.org/articles/PMC6587565
http://europepmc.org/articles/PMC6587565
Autor:
Kasper Kyhl, Søren Fabricius, Kiril Aleksov Ahtarovski, Lars Nepper-Christensen, Jacob Lønborg, Lene Holmvang, Ulrik Mouritzen, Kari Saunamäki, Christoffer Göransson, Lars Køber, Niels Vejlstrup, Göran Olivecrona, Steffen Helqvist, A Steensberg, Erik Jørgensen, Litten Bertelsen, Lene Kløvgaard, Jens Flensted Lassen, Frants Pedersen, Hans-Henrik Tilsted, Henning Kelbæk, Thomas Engstrøm
Publikováno v:
Heart. 104:1593-1599
ObjectivesReperfusion immediately after reopening of the infarct-related artery in ST-segment elevation myocardial infarction (STEMI) may cause myocardial damage in addition to the ischaemic insult (reperfusion injury). The gap junction modulating pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d5f0a1d5268413dc459c67363966f5
https://doi.org/10.1136/heartjnl-2017-312774
https://doi.org/10.1136/heartjnl-2017-312774
Autor:
Ulrike Hövelmann, Daniela Lamers, Britta Væver Bysted, Tim Heise, Francesca Macchi, Birgit Kronshage, Daniél Vega Møller, Ulrik Mouritzen
Publikováno v:
Diabetes Care. 41:531-537
OBJECTIVE Treatment of severe hypoglycemia outside of the hospital setting is limited to glucagon formulations requiring reconstitution before use, which may lead to erroneous or delayed glucagon administration. We compared the pharmacokinetic (PK) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dad669fe5b3536a0d21f7a36b558406
https://doi.org/10.2337/dc17-1402
https://doi.org/10.2337/dc17-1402
Autor:
Ulrike Hoevelmann, Ramin Tehranchi, Thomas R. Pieber, Ronnie Aronson, Ulrik Mouritzen, Julie Willard, Leona Plum-Moerschel
Publikováno v:
Diabetes. 68
Introduction: Severe hypoglycemia is one of the most feared adverse outcomes of insulin therapy and requires urgent assistance. The use of currently available glucagon products for rescue treatment of severe hypoglycemia is limited by complex reconst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9002e1bbfc8715096d857d14d612d95
https://doi.org/10.2337/db19-286-or
https://doi.org/10.2337/db19-286-or
Autor:
Hannelouise Kissow, Nikolaj Nerup, Lars O. Dragsted, L. H. Enevoldsen, A Steensberg, Rahim M. Naimi, Jens Pedersen, Steen Seier Poulsen, Lars Bo Svendsen, Stefan Fuglsang, Palle Jeppesen, Bolette Hartmann, Michael Patrick Achiam, Jens J. Holst, Mark Hvistendahl, Mark Berner Hansen, Rikard Ambrus, Ulrik Mouritzen, Svend Høime Hansen, Jan L. Madsen
Publikováno v:
The lancet. Gastroenterologyhepatology. 4(5)
Summary Background Patients with short bowel syndrome might have impaired postprandial endogenous glucagon-like peptide-2 (GLP-2) secretion, which is required for optimal intestinal adaptation. We aimed to assess the therapeutic potential of glepaglu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3925369e7e8148aadbc5f28dccb9f603
https://pubmed.ncbi.nlm.nih.gov/30880175
https://pubmed.ncbi.nlm.nih.gov/30880175
Autor:
Claire E. Hills, Gareth Price, Bethany M Williams, Paul E. Squires, Ulrik Mouritzen, Joe A. Potter
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2809, p 2809 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 6
International Journal of Molecular Sciences
Volume 22
Issue 6
Chronic kidney disease (CKD) is a global health problem associated with a number of comorbidities. Recent evidence implicates increased hemichannel-mediated release of adenosine triphosphate (ATP) in the progression of tubulointerstitial fibrosis, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99493cad70d27df910c4542b5d3697dc
https://doi.org/10.3390/ijms22062809
https://doi.org/10.3390/ijms22062809